Equillium & Biocon Expand Exclusive Licensing Agreement For Itolizumab To Include Australia And…
Equillium Inc. a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop products to treat severe autoimmune and inflammatory disorders, and…
Read More...
Read More...
